Results 111 to 120 of about 16,352 (275)

Combined oral contraceptives: evolution of the relationship benefit/risk

open access: yesБезопасность и риск фармакотерапии, 2018
Currently, more than 100 million women worldwide use combined oral contraceptives. Risk/benefit ratio of this group of drugs over the half-century history is largely changed in the direction of safety.
O. S. Alyautdina
doaj  

Is Shifting to a Progestin Worthwhile When Estrogen—Progestins Are Inefficacious for Endometriosis-Associated Pain?

open access: green, 2018
Paolo Vercellini   +5 more
openalex   +2 more sources

Association of Menopause and Hormonal Contraceptive Use With Chronic Rhinosinusitis: An “All of Us” Analysis

open access: yesOtolaryngology–Head and Neck Surgery, Volume 174, Issue 2, Page 347-358, February 2026.
Abstract Objective The role of sex hormones in inflammation has attracted increased attention, but the impact of hormone‐modifying states in chronic rhinosinusitis (CRS) has not been thoroughly studied. We aim to investigate the association of menopause and systemic hormonal contraceptive (SHC) use with both CRS with (CRSwNP) and without (CRSsNP) nasal
Abraham Ahn   +5 more
wiley   +1 more source

Letrozole cotreatment with progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing IVF treatment [PDF]

open access: gold, 2022
Yali Liu   +7 more
openalex   +1 more source

Mixed Gonadal Dysgenesis: A Comprehensive Review of Clinical Spectrum, Diagnostic Strategies, and Management Approaches

open access: yesClinical Endocrinology, Volume 104, Issue 2, Page 92-102, February 2026.
ABSTRACT Background Mixed gonadal dysgenesis (MGD) is a rare form of differences in sex development (DSD) typically associated with 45,X/46,XY mosaicism. The phenotypic presentation of MGD varies from atypical genitalia to typical male or female appearances often associated with Turner stigmata.
Dinesh Giri   +6 more
wiley   +1 more source

European Code Against Cancer, 5th edition – hormone replacement therapy, other common medical therapies and cancer

open access: yesMolecular Oncology, Volume 20, Issue 1, Page 117-133, January 2026.
The 5th edition of the European Code Against Cancer (ECAC5) contains 14 recommendations on cancer prevention. Here, we update the cancer prevention recommendations regarding the use of hormone replacement therapy (HRT), which is positioned as recommendation number 13 of the ECAC5.
Mangesh A. Thorat   +18 more
wiley   +1 more source

Microfabricated Neural Biosensors for Detection of Neurotransmitters, Biomarkers, and Small Molecules: Emerging Trends on Self‐Sustained Systems and Energy Harvesting

open access: yesAdvanced Sensor Research, Volume 5, Issue 1, January 2026.
This paper reviews the state of the art and recent developments in thin‐film biosensors for the detection of neurotransmitters, small molecules, and biomarkers within flexible, implantable bioelectronic systems. It covers the main sensing modalities, including electrochemical, plasmonic, acoustic, and magnetic, alongside their materials, transduction ...
Massimo Mariello
wiley   +1 more source

Lipid‐Driven OLR1/FOXM1/FGF19 Axis Orchestrates Crosstalk in an Epithelial‐Fibroblast Positive Feedback Promoting Progesterone Resistance in Endometrial Cancer

open access: yesAdvanced Science, Volume 13, Issue 6, 30 January 2026.
It is revealed that a metabolic–stromal loop driven by oxLDL–OLR1–FOXM1–FGF19 signaling promotes progesterone resistance in endometrial cancer. OxLDL activates epithelial–fibroblast crosstalk, enhancing proliferation and hormonal insensitivity. Disruption of this circuit, especially with resveratrol, restores MPA sensitivity, highlighting a potential ...
Xingchen Li   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy